Jonathan Elliott, Ph.D., is interviewed on OPB-Radio’s Think Out Loud about a new research award to discover whether bright-light therapy to improve sleep for people with traumatic brain injuries potentially forestalls neurodegenerative conditions like Parkinson’s and Alzheimer’s.

A study co-authored by researchers at OHSU and the Karolinska Institute suggests social media may be damaging concentration levels and contributing to an increase in cases of attention deficit hyperactivity disorder.

OHSU research suggests insufficient sleep may shorten your life. Andrew McHill, Ph.D., says, “We’ve always thought sleep is important, but this research really drives that point home: People really should strive to get seven to nine hours of sleep if at all possible.”

OHSU-PSU School of Public Health research describes the potential impacts of delayed vaccination for hepatitis B in children. Eric Hall, Ph.D., says, “I don’t think many of us in the public health community thought six or eight months ago they would be looking at changing the infant hepatitis B vaccination schedule. This has been a great public health success. There has been no new evidence to arise that would indicate there’s any type of risk around hepatitis B vaccination for infants. With that in mind, I’m not entirely sure what’s next.”

OHSU research finds untreated obstructive sleep apnea nearly doubles Parkinson's disease risk, but early CPAP treatment improves outcomes.

OHSU-PSU School of Public Health research describes the potential impacts of delayed vaccination for hepatitis B in children. Eric Hall, Ph.D., says, “I don’t think many of us in the public health community thought six or eight months ago they would be looking at changing the infant hepatitis B vaccination schedule. This has been a great public health success. There has been no new evidence to arise that would indicate there’s any type of risk around hepatitis B vaccination for infants. With that in mind, I’m not entirely sure what’s next.”

OHSU-PSU School of Public Health research describes the potential impacts of delayed vaccination for hepatitis B in children. Eric Hall, Ph.D., says, “I don’t think many of us in the public health community thought six or eight months ago they would be looking at changing the infant hepatitis B vaccination schedule. This has been a great public health success. There has been no new evidence to arise that would indicate there’s any type of risk around hepatitis B vaccination for infants. With that in mind, I’m not entirely sure what’s next.”

OHSU-PSU School of Public Health research describes the potential impacts of delayed vaccination for hepatitis B in children. Eric Hall, Ph.D., says, “I don’t think many of us in the public health community thought six or eight months ago they would be looking at changing the infant hepatitis B vaccination schedule. This has been a great public health success. There has been no new evidence to arise that would indicate there’s any type of risk around hepatitis B vaccination for infants. With that in mind, I’m not entirely sure what’s next.”

The Lund Report covers OHSU research that finds corporate ownership of direct primary care and concierge medical clinics that charge a fee for a package of services has grown in the past five years from about 9% in 2018 to one-third in 2023. Jane Zhu, M.D., says, “DPC and concierge practices are often sold as sort of an alternative to the large corporate-owned practices that have been taking over the primary care landscape in recent years. And yet we're seeing that similar ownership structures are clearly taking hold in these alternative models of primary care."

OHSU-PSU School of Public Health research describes the potential impacts of delayed vaccination for hepatitis B in children. Eric Hall, Ph.D., says, “I don’t think many of us in the public health community thought six or eight months ago they would be looking at changing the infant hepatitis B vaccination schedule. This has been a great public health success. There has been no new evidence to arise that would indicate there’s any type of risk around hepatitis B vaccination for infants. With that in mind, I’m not entirely sure what’s next.”